Dendracin Neurodendraxcin
NDC Package 50436-0165-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Dendracin Neurodendraxcin is use only as directed. Marketed by Unit Dose Services, this product is identified by NDC 50436-0165 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
50436-0165-1
Package Description
120 mL in 1 BOTTLE
Product Code
50436-0165
11-Digit Billing Format
50436016501
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
120 ML
RxNorm Crosswalk
  • RxCUI: 1116967 - capsaicin 0.025 % / menthol 10 % / methyl salicylate 30 % Topical Lotion
  • RxCUI: 1116967 - capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion
  • RxCUI: 1116971 - DENDRACIN Neurodendraxcin 0.025 % / 10 % / 30 % Topical Lotion
  • RxCUI: 1116971 - capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Dendracin Neurodendraxcin]
  • RxCUI: 1116971 - Dendracin Neurodendraxcin (capsaicin 0.025 % / menthol 10 % / methyl salicylate 30 % ) Topical Lotion

Clinical Specifications

Proprietary Name
Dendracin Neurodendraxcin
Dosage Form
-
Usage Information
Use only as directed. Shake before each use. Prior to first use, rub small amount to check for sensitivity. Gently rub over painful areas. Dry before contact with clothes or bedding to avoid staining. Wash hands after use. Do not use more than 4 times daily or if pregnant or nursing. If swallowed, call poison control. If placed into eyes, rinse with cold water and call a doctor.

Regulatory & Marketing

Labeler Name
Unit Dose Services
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
07-22-2011
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50436-0165-1 identifies a specific commercial package of 120 ml in 1 bottle of Dendracin Neurodendraxcin, labeled by Unit Dose Services. This product is billed per "ML" milliliter and contains an estimated amount of 120 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Unit Dose Services on July 22, 2011. The current certification is valid through December 31, 2019.

How is this Unit Dose Services product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50436016501. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 120 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50436-0165-1
11-Digit CMS (5-4-2)
50436-0165-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.